Abstract

Duchenne muscular dystrophy (DMD) is characterized by rapid wasting of skeletal muscle. Mitochondrial dysfunction is a well-known pathological feature of DMD. However, whether mitochondrial dysfunction occurs before muscle fiber damage in DMD pathology is not well known. Furthermore, the impact upon heterozygous female mdx carriers (mdx/+), who display dystrophin mosaicism, has received little attention. We hypothesized that dystrophin deletion leads to mitochondrial dysfunction, and that this may occur before myofiber necrosis. As a secondary complication to mitochondrial dysfunction, we also hypothesized metabolic abnormalities prior to the onset of muscle damage. In this study, we detected aberrant mitochondrial morphology, reduced cristae number, and large mitochondrial vacuoles from both male and female mdx mice prior to the onset of muscle damage. Furthermore, we systematically characterized mitochondria during disease progression starting before the onset of muscle damage, noting additional changes in mitochondrial DNA copy number and regulators of mitochondrial size. We further detected mild metabolic and mitochondrial impairments in female mdx carrier mice that were exacerbated with high-fat diet feeding. Lastly, inhibition of the strong autophagic program observed in adolescent mdx male mice via administration of the autophagy inhibitor leupeptin did not improve skeletal muscle pathology. These results are in line with previous data and suggest that before the onset of myofiber necrosis, mitochondrial and metabolic abnormalities are present within the mdx mouse.

Highlights

  • Muscular dystrophies are a family of genetic disorders manifesting primarily by the progressive wasting of skeletal muscle

  • Gene expression for the inflammatory cytokines IFNγ, interleukin 10 (IL10), interleukin 6 (IL6), and TNFα were elevated by approximately 4.5 to 7.5-fold in mdx males compared with age-matched controls (Figure 1A)

  • We observed substantial reductions of genes related to mitochondrial fission (Dnm1l, Mff, and Fis1) and mitophagy (Maplc3b and PTEN induced putative kinase 1 (Pink1)) in mdx mice vs. age-matched controls (Figure 1A)

Read more

Summary

Introduction

Muscular dystrophies are a family of genetic disorders manifesting primarily by the progressive wasting of skeletal muscle. Duchenne muscular dystrophy (DMD) is the most severe and frequent muscular dystrophy with most patients having little, if any, detectable dystrophin within muscle (Monaco et al, 1988; Emery, 1989; Govoni et al, 2013; De Palma et al, 2014). DMD patients present with clinical manifestations early in life and experience progressively deteriorating muscles until eventual passing before age 30 (Davies et al, 1988; Pichavant et al, 2011). DMD treatments delay disease progression or mitigate its symptoms, but frequently produce adverse side effects (Muntoni et al, 2002; Dubowitz, 2005; Bushby et al, 2010a,b). Mdx muscles share some histological features with DMD, the phenotype is less severe, concerning the associated cardiomyopathy and respiratory dysfunction that is life-threatening in DMD (McIntosh et al, 1998a,b)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call